UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Physiological effects of intravenous fructose 1.6-diphosphate on diaphragmatic function in malnourished patients with COPD

Monaldi archives for chest disease, 2004-10, Vol.61 (4), p.203-208

2004

Volltextzugriff (PDF)

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

The American review of respiratory disease, 1992-06, Vol.145 (6), p.1285

1992

Volltextzugriff (PDF)

Interaction study of fenoldopam-digoxin in congestive heart failure

European journal of clinical pharmacology, 1989-01, Vol.37 (4), p.395-397

1989

Volltextzugriff (PDF)

BIOAVAILABILITY OF TEMAZEPAM IN SOFT GELATIN CAPSULES

British journal of clinical pharmacology, 1979-01, Vol.8 (Supplement s1), p.31S-35S

FUCCELLA, L.M.

1979

Volltextzugriff (PDF)

Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules

European journal of clinical pharmacology, 1977-12, Vol.12 (5), p.383-386

1977

Volltextzugriff (PDF)

Beta-blockade and emotional tachycardia; radiotelemetric investigations in ski jumpers

Journal of applied physiology (1948), 1969-09, Vol.27 (3), p.366-369

1969

Volltextzugriff (PDF)

Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920)

Haematologica (Roma), 1981-04, Vol.66 (2), p.160

1981

Volltextzugriff (PDF)

Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man

European journal of clinical pharmacology, 1979-06, Vol.15 (5), p.323-327

1979

Volltextzugriff (PDF)

Pharmacokinetics and metabolism of premazepam, a new potential anxiolytic, in humans

International journal of clinical pharmacology, therapy, and toxicology, 1984-05, Vol.22 (5), p.273

1984

Volltextzugriff (PDF)

Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man

European journal of clinical pharmacology, 1979-06, Vol.15 (5), p.329-333

1979

Volltextzugriff (PDF)

Inhibition of lipolysis by nicotinic acid and by acipimox

Clinical pharmacology and therapeutics, 1980-12, Vol.28 (6), p.790-795

1980

Volltextzugriff (PDF)

Double‐blind study of the analgesic effect of indoprofen (K 4277)

Clinical pharmacology and therapeutics, 1975-03, Vol.17 (3), p.277-283

1975

Volltextzugriff (PDF)

Study of physiological availability of temazepam in man

International journal of clinical pharmacology, therapy and toxicology, 1972-11, Vol.6 (4), p.303

1972

Volltextzugriff (PDF)

Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy

International journal of cardiology, 1989-03, Vol.22 (3), p.381-387

1989

Volltextzugriff (PDF)

Application of Nonparametric Procedure for Bioassay Data to the Evaluation of Analgesics in Man

Journal of clinical pharmacology, 1977-04, Vol.17 (4), p.177-185

1977

Volltextzugriff (PDF)

Clinical Pharmacology Studies with Indobufen (K 3920): Inhibitor of Platelet Aggregation

Journal of clinical pharmacology, 1980-05, Vol.20 (5-6), p.316-325

1980

Volltextzugriff (PDF)

Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis

Atherosclerosis, 1981-02, Vol.38 (3-4), p.267

1981

Volltextzugriff (PDF)

Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure

Cardiovascular drugs and therapy, 1989-11, Vol.3 (6), p.897-902

1989

Volltextzugriff (PDF)

Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man-Comparison with Glibenclamide

The Journal of Clinical Pharmacology and New Drugs, 1973-02, Vol.13 (2-3), p.68-75

1973

Volltextzugriff (PDF)

Clinical pharmacology of inhibitors of platelet aggregation

Pharmacological research communications, 1979-11, Vol.11 (10), p.825-852

Fuccella, Luciano M.

1979

Volltextzugriff (PDF)

Gastro-intestinal blood loss during administration of indoprofen, aspirin and ibuprofen

Journal of international medical research, 1977, Vol.5 (3), p.155

1977

Volltextzugriff (PDF)

Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man

European journal of clinical pharmacology, 1973-12, Vol.6 (4), p.256-260

1973

Volltextzugriff (PDF)

BEHAVIORAL EFFECTS OF CARDIOVASCULAR DRUGS

Clinical neuropharmacology, 1984-06, Vol.7, p.S490-S492

Fuccella, L. M.

1984

Volltextzugriff (PDF)

Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man

European journal of clinical pharmacology, 1971-12, Vol.4 (1), p.12-17

1971

Volltextzugriff (PDF)

Pharmacokinetics and bioavailability of indoprofen in man

European journal of clinical pharmacology, 1976-01, Vol.10 (3-4), p.257-262

1976

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(53)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Physiological effects of intravenous fructose 1.6-diphosphate on diaphragmatic function in malnourished patients with COPD

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

Interaction study of fenoldopam-digoxin in congestive heart failure

BIOAVAILABILITY OF TEMAZEPAM IN SOFT GELATIN CAPSULES

Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules

Beta-blockade and emotional tachycardia; radiotelemetric investigations in ski jumpers

Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920)

Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man

Pharmacokinetics and metabolism of premazepam, a new potential anxiolytic, in humans

Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man

Inhibition of lipolysis by nicotinic acid and by acipimox

Double‐blind study of the analgesic effect of indoprofen (K 4277)

Study of physiological availability of temazepam in man

Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy

Application of Nonparametric Procedure for Bioassay Data to the Evaluation of Analgesics in Man

Clinical Pharmacology Studies with Indobufen (K 3920): Inhibitor of Platelet Aggregation

Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis

Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure

Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man-Comparison with Glibenclamide

Clinical pharmacology of inhibitors of platelet aggregation

Gastro-intestinal blood loss during administration of indoprofen, aspirin and ibuprofen

Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man

BEHAVIORAL EFFECTS OF CARDIOVASCULAR DRUGS

Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man

Pharmacokinetics and bioavailability of indoprofen in man

Suchergebnisse filtern